•Screening and management of coccidioidomycosis in patients with inflammatory bowel disease on immunosuppressive therapies
•Reconsidering therapeutic strategies after biologic failure in ulcerative colitis: appendectomy versus Janus kinase inhibition
•PREDICT-UC, infliximab pharmacokinetics, and the pursuit of personalised rescue therapy in acute severe ulcerative colitis
•The overlooked surface: cutaneous manifestations of inflammatory bowel disease
•Patient-Reported Outcomes Are a Practical Tool for Monitoring Crohn's Disease Activity in Real-World Care